Organo Financial Statements From 2010 to 2025
Organo's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Organo's valuation are provided below:Organo does not presently have any trending fundamental ratios for analysis.
This module can also supplement various Organo Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Check Organo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organo's main balance sheet or income statement drivers, such as , as well as many indicators such as . Organo financial statements analysis is a perfect complement when working with Organo Valuation or Volatility modules.
Organo |
Organo Company Return On Equity Analysis
Organo's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Organo Return On Equity | 13.05 |
Most of Organo's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organo is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Organo has a Return On Equity of 13.05. This is much higher than that of the Industrials sector and notably lower than that of the Pollution & Treatment Controls industry. The return on equity for all United States stocks is notably lower than that of the firm.
Organo Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Organo's current stock value. Our valuation model uses many indicators to compare Organo value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organo competition to find correlations between indicators driving Organo's intrinsic value. More Info.Organo is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Organo is roughly 2.29 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organo's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Organo Pink Sheet
If you are still planning to invest in Organo check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Organo's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets |